Developing a Generic HT Assay for DuoBody ® Characterization AUTHOR Ewald van den Bremer, Ph.D., Genmab BV, Utrecht, The Netherlands INDUSTRY Biotechnology CUSTOMER SINCE 2015 ABOUT GENMAB Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. GENEDATA SOLUTION Background Genmab is an international biotechnology company that specializes in creating and developing antibody biotherapeutics for treating cancer. The innovative DuoBody technology platform facilitates generation of human IgG1 bispecific antibodies (bsAb) using a fast, scalable process. Predicting the behavior of bsAbs based on the activity of their parent antibodies is difficult, and therefore Genmab has dev

Join for free to read